Mackenzie Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338K | Sell |
1,402
-245
| -15% | -$59.1K | ﹤0.01% | 1354 |
|
|
2025
Q1 | $401K | Buy |
1,647
+1,018
| +162% | +$248K | ﹤0.01% | 1268 |
|
|
2024
Q4 | $207K | Buy |
+629
| New | +$207K | ﹤0.01% | 1553 |
|
|
2024
Q3 | – | Sell |
-1,054
| Closed | -$288K | – | 1586 |
|
|
2024
Q2 | $288K | Buy |
1,054
+322
| +44% | +$87.9K | ﹤0.01% | 1181 |
|
|
2024
Q1 | $253K | Sell |
732
-644
| -47% | -$223K | ﹤0.01% | 1250 |
|
|
2023
Q4 | $444K | Buy |
1,376
+444
| +48% | +$143K | ﹤0.01% | 1028 |
|
|
2023
Q3 | $327K | Sell |
932
-1,238
| -57% | -$434K | ﹤0.01% | 1110 |
|
|
2023
Q2 | $819K | Buy |
2,170
+342
| +19% | +$129K | ﹤0.01% | 899 |
|
|
2023
Q1 | $876K | Sell |
1,828
-661
| -27% | -$317K | ﹤0.01% | 886 |
|
|
2022
Q4 | $1.05M | Sell |
2,489
-1,443
| -37% | -$607K | ﹤0.01% | 777 |
|
|
2022
Q3 | $1.64M | Buy |
3,932
+2,005
| +104% | +$836K | ﹤0.01% | 734 |
|
|
2022
Q2 | $954K | Sell |
1,927
-3,569
| -65% | -$1.77M | ﹤0.01% | 845 |
|
|
2022
Q1 | $3.1M | Buy |
5,496
+144
| +3% | +$81.1K | ﹤0.01% | 673 |
|
|
2021
Q4 | $4.04M | Buy |
5,352
+166
| +3% | +$125K | 0.01% | 624 |
|
|
2021
Q3 | $3.87M | Buy |
5,186
+3,585
| +224% | +$2.67M | 0.01% | 627 |
|
|
2021
Q2 | $1.03M | Buy |
1,601
+449
| +39% | +$289K | ﹤0.01% | 859 |
|
|
2021
Q1 | $658K | Sell |
1,152
-1,913
| -62% | -$1.09M | ﹤0.01% | 877 |
|
|
2020
Q4 | $1.79M | Sell |
3,065
-1,020
| -25% | -$595K | ﹤0.01% | 624 |
|
|
2020
Q3 | $2.11M | Buy |
4,085
+343
| +9% | +$177K | 0.01% | 547 |
|
|
2020
Q2 | $1.69M | Buy |
3,742
+1,353
| +57% | +$611K | ﹤0.01% | 589 |
|
|
2020
Q1 | $837K | Buy |
+2,389
| New | +$837K | ﹤0.01% | 680 |
|
|
2019
Q4 | – | Sell |
-617
| Closed | -$205K | – | 1080 |
|
|
2019
Q3 | $205K | Buy |
+617
| New | +$205K | ﹤0.01% | 954 |
|
|
2013
Q3 | – | Sell |
-9,800
| Closed | -$1.1M | – | 606 |
|
|
2013
Q2 | $1.1M | Buy |
+9,800
| New | +$1.1M | 0.01% | 473 |
|